AARS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.339200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.673000E-01
Normal-vs-Stage2
2.380800E-01
Normal-vs-Stage3
1.548360E-01
Normal-vs-Stage4
7.106600E-01
Stage1-vs-Stage2
8.994400E-01
Stage1-vs-Stage3
1.302370E-01
Stage1-vs-Stage4
6.556400E-01
Stage2-vs-Stage3
8.190000E-02
Stage2-vs-Stage4
5.869600E-01
Stage3-vs-Stage4
3.258300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.420800E-01
Normal-vs-AfricanAmerican
7.177200E-01
Normal-vs-Asian
2.854400E-01
Caucasian-vs-AfricanAmerican
4.330400E-01
Caucasian-vs-Asian
6.891600E-01
AfricanAmerican-vs-Asian
4.059000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.076800E-01
Normal-vs-Female
1.778990E-01
Male-vs-Female
3.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.024200E-01
Normal-vs-Age(41-60Yrs)
3.158800E-01
Normal-vs-Age(61-80Yrs)
1.855230E-01
Normal-vs-Age(81-100Yrs)
7.321800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.898000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.845600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.927400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.809640E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.746000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.146960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.789600E-01
Normal-vs-Daily Drinker
9.784200E-02
Normal-vs-Weekly Drinker
4.907600E-01
Normal-vs-Occasional Drinker
2.551200E-01
Normal-vs-Social Drinker
6.381000E-01
Non Drinker-vs-Daily Drinker
3.798200E-01
Non Drinker-vs-Weekly Drinker
4.525800E-01
Non Drinker-vs-Occasional Drinker
7.609800E-01
Non Drinker-vs-Social Drinker
4.599000E-01
Daily Drinker-vs-Weekly Drinker
1.101610E-01
Daily Drinker-vs-Occasional Drinker
2.019000E-01
Daily Drinker-vs-Social Drinker
7.587600E-02
Weekly Drinker-vs-Occasional Drinker
5.899000E-01
Weekly Drinker-vs-Social Drinker
9.179000E-01
Occasional Drinker-vs-Social Drinker
5.898400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.952000E-01
Normal-vs-Grade 2
7.385200E-01
Normal-vs-Grade 3
7.208400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.037000E-01
Grade 1-vs-Grade 3
8.982800E-01
Grade 1-vs-Grade 4
3.952000E-01
Grade 2-vs-Grade 3
6.802400E-01
Grade 2-vs-Grade 4
7.385200E-01
Grade 3-vs-Grade 4
7.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.304430E-01
Normal-vs-NonDiabetic
2.392400E-01
Diabetic-vs-NonDiabetic
1.547030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.829600E-01
Normal-vs-NoPancreatitis
2.033200E-01
Pancreatitis-vs-NoPancreatitis
6.644000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.967000E-01
Normal-vs-N1
2.403400E-01
N0-vs-N1
7.735200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.898800E-01
Normal-vs-TP53-NonMutant
5.406200E-01
TP53-Mutant-vs-TP53-NonMutant
6.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
